NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 66 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,248 | +18.5% | 1,504 | 0.0% | 0.00% | – |
| Q1 2023 | $1,053 | +3.3% | 1,504 | -24.8% | 0.00% | – |
| Q4 2022 | $1,019 | +1.9% | 2,001 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,001 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -88.2% | 2,001 | -77.3% | 0.00% | – |
| Q1 2022 | $17,000 | +466.7% | 8,800 | +1157.1% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 700 | +600.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |